| Dr Ernest Yeboah Agyemang, PHARMD | |
|
5650 Plank Rd, Fredericksburg, VA 22407-6641 | |
| (540) 786-5883 | |
| (540) 785-9088 |
| Full Name | Dr Ernest Yeboah Agyemang |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 5650 Plank Rd, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093364408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202218164 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ernest Yeboah Agyemang, PHARMD 5650 Plank Rd, Fredericksburg, VA 22407-6641 Ph: (540) 786-5883 | Dr Ernest Yeboah Agyemang, PHARMD 5650 Plank Rd, Fredericksburg, VA 22407-6641 Ph: (540) 786-5883 |
News Archive
IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, announced that Diamedix Corporation, IVAX Diagnostics' wholly-owned subsidiary located in Miami, Florida, has signed a three-year agreement with Laboratory Supply Company, the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States.
A new prosthesis powered by microscopic electrodes implanted in the thigh muscles of the wearer transmits natural sensations when the limb is touched, as well as with the movement of the limb.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis.
› Verified 7 days ago
Dr. Jessica Nomm, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 Hospital Dr, Fredericksburg, VA 22401 Phone: 540-368-3700 | |
Alima Fonderson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 Plank Rd, Fredericksburg, VA 22407 Phone: 540-786-3008 Fax: 540-786-1931 | |
Meredith Moore, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 591 Jefferson Davis Hwy, Fredericksburg, VA 22401 Phone: 540-809-5763 | |
Pamela Kittoe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 Hospital Dr, Fredericksburg, VA 22401 Phone: 540-368-3800 | |
Ellen Ko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10115 Blandfield Ln, Fredericksburg, VA 22408 Phone: 612-812-0246 | |
Susan Mcknight Sprow, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25 S Gateway Dr, T-2175, Fredericksburg, VA 22406 Phone: 540-374-4821 | |
So Rin Yi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25 S Gateway Dr, Fredericksburg, VA 22406 Phone: 540-374-4820 |